Locations:

Tag: prostate cancer

Crystal structure of mouse PD1 PDL2 complex 650×450

June 19, 2019/Cancer

PD-L2: A Viable Prognostic Biomarker in Prostate Cancer

This cell surface protein could be an immune checkpoint inhibition target

June 17, 2019/Cancer

Study Verifies IsoPSA’s Utility as a Prostate Cancer Biomarker

Test can identify aggressive vs. indolent disease, reduce unneeded biopsies

March 14, 2019/Cancer

Active Surveillance a Reasonable Option in African-American Men with Low-Risk Prostate Cancer

Study sheds new light on the utility of watchful waiting

March 5, 2019/Cancer

Study Demonstrates Association Between Urologic Oncology Fellowship Training and Diagnostic Yield on Prostate Biopsy

Advanced training is linked to positive biopsy findings

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 22, 2019/Cancer

Study Validates Clinical Criteria for Very High-Risk Localized Prostate Cancer

Data analyzed from three centers

October 29, 2018/Cancer

Prostate Cancer Today: A 2-Minute Update for Physicians

5 major advances usher in a new, hopeful era

October 22, 2018/Cancer/Research

Ten-Year Outcomes of Moderately Hypofractionated IMRT in Prostate Cancer

Higher doses don’t mean higher toxicity

October 12, 2018/Cancer/Genomics

Using Next-Generation Sequencing to Target Tumor Genomics in Metastatic Prostate Cancer

Actionability of tumor DNA data remains limited

October 4, 2018/Cancer

PSA Testing: A Brief Note on Current Thinking

The short answer from the front line of prostate cancer screening

October 2, 2018/Basic & Translational Science

Functional PET Imaging to Identify Prostate Cancer Treatment Resistance

Research has clear implications for future of prostate cancer imaging

BackPage 3 of 6Next